Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) New York MDRU |
---|---|
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00015275 |
The purpose of this study is to define pathophysiological subtypes of abnormalities in subjects with cocaine dependence.
Condition | Intervention | Phase |
---|---|---|
Cocaine-Related Disorders Substance-Related Disorders |
Behavioral: Cocaine-Related Disorders |
Phase IV |
Study Type: | Interventional |
Study Design: | Diagnostic, Open Label |
Official Title: | Pathophysiological Subtyping of Abnormalities in Cocaine Dependence |
Estimated Enrollment: | 0 |
The objective of this study is to define subgroups of patients with differential treatment outcome on the basis of differential baseline electrophysiological clusters.
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Cocaine dependence. Seeking residential treatment.
Study ID Numbers: | NIDA-5-0013-9, Y01-5-0013-9 |
Study First Received: | April 18, 2001 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00015275 |
Health Authority: | United States: Federal Government |
Cocaine-Related Disorders Dopamine Mental Disorders Substance-Related Disorders |
Disorders of Environmental Origin Cocaine Congenital Abnormalities |
Dopamine Uptake Inhibitors Neurotransmitter Agents Neurotransmitter Uptake Inhibitors Disease Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Central Nervous System Depressants Anesthetics Cardiovascular Agents |
Pharmacologic Actions Anesthetics, Local Pathologic Processes Sensory System Agents Therapeutic Uses Vasoconstrictor Agents Dopamine Agents Peripheral Nervous System Agents Central Nervous System Agents |